Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide
- PMID: 15105817
- DOI: 10.1038/sj.eye.6701395
Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide
Abstract
Purpose: To evaluate the effect of intravitreal triamcinolone acetonide on visual acuity in branch retinal vein occlusion.
Methods: The prospective comparative nonrandomized clinical interventional study included 28 patients (28 eyes) with branch retinal vein occlusion. The study group consisting of 10 consecutive patients received an intravitreal injection of 20-25 mg of triamcinolone acetonide. The control group including 18 patients did not receive an intravitreal injection. The mean follow-up was 8.7+/-4.4 months.
Results: In the study group, mean visual acuity increased significantly (P=0.02) from 0.27+/-0.11 preoperatively to a best postoperative visual acuity of 0.45+/-0.27. Visual acuity measurements determined 1 month after the injection were significantly (P=0.027) higher than baseline values. Nine (90%) eyes gained in visual acuity, with six (60%) eyes showing an increase in visual acuity of at least two Snellen lines. In the ischaemic subgroup, visual acuity did not change significantly (0.18+/-0.18 to 0.13+/-0.04; P=0.66), while, in the nonischaemic subgroup, visual acuity increased significantly (P=0.012) from the baseline value to the best postoperative measurement (0.29+/-0.09 to 0.53+/-0.24). In the control group, baseline visual acuity and best visual acuity during the follow-up did not vary significantly (P=0.27). Comparing the study and control groups with each other, the gain in visual acuity was significantly higher in the study group at 1 month (P=0.016) and 2 months (P=0.012) after baseline.
Conclusions: Intravitreal injection of triamcinolone acetonide can increase visual acuity in patients with branch retinal vein occlusion.
Comment in
-
Reply to intrevitreal triamcinolone for branch retinal vein occlusion.Eye (Lond). 2006 Jun;20(6):727-8; author reply 728. doi: 10.1038/sj.eye.6701947. Epub 2005 Jul 8. Eye (Lond). 2006. PMID: 16021196 No abstract available.
Similar articles
-
Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.Eye (Lond). 2008 Jan;22(1):60-4. doi: 10.1038/sj.eye.6702518. Epub 2006 Aug 11. Eye (Lond). 2008. PMID: 16902493
-
Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion.Kaohsiung J Med Sci. 2006 Jul;22(7):321-30. doi: 10.1016/S1607-551X(09)70318-3. Kaohsiung J Med Sci. 2006. PMID: 16849100
-
Intravitreal triamcinolone acetonide for treatment of persistent macular oedema in branch retinal vein occlusion.Eye (Lond). 2006 Jan;20(1):13-7. doi: 10.1038/sj.eye.6701803. Eye (Lond). 2006. PMID: 15723039 Clinical Trial.
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
-
Acute idiopathic frosted branch angiitis in an 11-month-old infant treated with intravitreal triamcinolone acetonide.J AAPOS. 2012 Oct;16(5):487-8. doi: 10.1016/j.jaapos.2012.06.002. J AAPOS. 2012. PMID: 23084392 Review.
Cited by
-
The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems.Biomedicines. 2023 Jul 5;11(7):1901. doi: 10.3390/biomedicines11071901. Biomedicines. 2023. PMID: 37509540 Free PMC article. Review.
-
Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up.J Ophthalmol. 2020 Feb 11;2020:6830148. doi: 10.1155/2020/6830148. eCollection 2020. J Ophthalmol. 2020. PMID: 32104595 Free PMC article.
-
Raised intraocular pressure following Intravitreal Triamcinolone Acetonide in diabetic versus non-diabetic patients.Pak J Med Sci. 2018 Sep-Oct;34(5):1110-1114. doi: 10.12669/pjms.345.13174. Pak J Med Sci. 2018. PMID: 30344559 Free PMC article.
-
The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario.Indian J Ophthalmol. 2018 Jun;66(6):831-836. doi: 10.4103/ijo.IJO_1259_17. Indian J Ophthalmol. 2018. PMID: 29785994 Free PMC article.
-
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study.Ophthalmologica. 2018;240(2):81-89. doi: 10.1159/000487547. Epub 2018 Apr 11. Ophthalmologica. 2018. PMID: 29642062 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources